Page last updated: 2024-10-26

diclofenac and Lipodystrophy, Intestinal

diclofenac has been researched along with Lipodystrophy, Intestinal in 1 studies

Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.

Research Excerpts

ExcerptRelevanceReference
"When Whipple's disease was diagnosed this treatment was stopped and antibiotics (ceftriaxone) was started and then continued with co-trimoxazole for one year with significantly improvement in her condition."1.35[Whipple's disease with normal duodenal histology and ankylosing spondylitis]. ( Ahmadi-Simab, K; Schnitzler, P, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmadi-Simab, K1
Schnitzler, P1

Other Studies

1 other study available for diclofenac and Lipodystrophy, Intestinal

ArticleYear
[Whipple's disease with normal duodenal histology and ankylosing spondylitis].
    Deutsche medizinische Wochenschrift (1946), 2009, Volume: 134, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Ceftriaxone; Diagnosi

2009